Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MXWL

Maxwell

$4.75

-0.27 (-5.38%)

, SU

Suncor

09:40
11/16/17
11/16
09:40
11/16/17
09:40
Options
Unusually active option classes on open November 16th »

Unusual total active…

MXWL

Maxwell

$4.75

-0.27 (-5.38%)

SU

Suncor

BBY

Best Buy

MOMO

Momo

$30.59

1.4 (4.80%)

ROKU

Roku

$39.32

2.37 (6.41%)

MRK

Merck

EWZ

MSCI Brazil Index

PBR

Petrobras

SVXY

ProShares Short VIX Short-Term Futures

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 16

    Nov

  • 28

    Nov

  • 30

    Nov

  • 05

    Dec

  • 14

    Dec

  • 02

    Feb

RHHBY

Roche

$28.73

-0.12 (-0.42%)

, ABBV

AbbVie

$93.76

-0.99 (-1.04%)

05:33
11/16/17
11/16
05:33
11/16/17
05:33
Recommendations
Roche, AbbVie, Novartis, Bayer, Johnson & Johnson, Zoetis, Eli Lilly, Merck, Novo Nordisk, AstraZeneca analyst commentary at Jefferies »

Jefferies names Roche new…

RHHBY

Roche

$28.73

-0.12 (-0.42%)

ABBV

AbbVie

$93.76

-0.99 (-1.04%)

NVS

Novartis

$82.60

-0.43 (-0.52%)

BAYRY

Bayer

$31.97

-0.04 (-0.12%)

JNJ

Johnson & Johnson

$139.10

-0.39 (-0.28%)

ZTS

Zoetis

$69.62

-0.28 (-0.40%)

LLY

Eli Lilly

$82.19

-0.3 (-0.36%)

MRK

Merck

$54.80

-0.19 (-0.35%)

NVO

Novo Nordisk

$49.67

-0.17 (-0.34%)

AZN

AstraZeneca

$33.39

0.14 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 16

    Nov

  • 16

    Nov

  • 28

    Nov

  • 30

    Nov

  • 30

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 14

    Dec

  • 23

    Dec

  • 02

    Feb

  • 23

    Feb

  • 17

    May

Wednesday
MRK

Merck

$54.80

-0.19 (-0.35%)

, SPRO

Spero Therapeutics

$13.36

-0.93 (-6.51%)

16:51
11/15/17
11/15
16:51
11/15/17
16:51
Hot Stocks
Breaking Hot Stocks news story on Merck, Spero Therapeutics »

Merck reports 6.5%…

MRK

Merck

$54.80

-0.19 (-0.35%)

SPRO

Spero Therapeutics

$13.36

-0.93 (-6.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 14

    Dec

  • 02

    Feb

AGEN

Agenus

$3.50

-0.15 (-4.11%)

, MRK

Merck

09:27
11/15/17
11/15
09:27
11/15/17
09:27
Hot Stocks
Agenus receives $4M in license fee from Merck »

Agenus (AGEN) received a…

AGEN

Agenus

$3.50

-0.15 (-4.11%)

MRK

Merck

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

  • 30

    Nov

  • 14

    Dec

  • 02

    Feb

MRK

Merck

$54.99

-0.11 (-0.20%)

08:36
11/15/17
11/15
08:36
11/15/17
08:36
Recommendations
Merck analyst commentary at Bernstein »

Merck Keynote-042 trial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 14

    Dec

  • 02

    Feb

Over a week ago
PFE

Pfizer

$35.23

0.05 (0.14%)

, BIIB

Biogen

$310.44

0.48 (0.15%)

10:35
11/13/17
11/13
10:35
11/13/17
10:35
Hot Stocks
BMO argues for Biogen as most logical takeover target for Pfizer »

Commenting on…

PFE

Pfizer

$35.23

0.05 (0.14%)

BIIB

Biogen

$310.44

0.48 (0.15%)

BMY

Bristol-Myers

$60.77

-0.09 (-0.15%)

MRK

Merck

$55.37

-0.11 (-0.20%)

AZN

AstraZeneca

$32.85

-0.06 (-0.18%)

LLY

Eli Lilly

$83.02

-0.27 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

  • 28

    Nov

  • 30

    Nov

  • 14

    Dec

  • 02

    Feb

  • 05

    Mar

ARRY

Array BioPharma

$11.00

0.18 (1.66%)

, MRK

Merck

$55.48

-0.73 (-1.30%)

08:09
11/13/17
11/13
08:09
11/13/17
08:09
Hot Stocks
Array BioPharma reports initial from Phase 1b trial of ARRY-382 with KEYTRUDA »

Array BioPharma (ARRY)…

ARRY

Array BioPharma

$11.00

0.18 (1.66%)

MRK

Merck

$55.48

-0.73 (-1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 16

    Nov

  • 28

    Nov

  • 30

    Nov

  • 14

    Dec

  • 02

    Feb

  • 30

    Jun

  • 30

    Jun

MRK

Merck

$55.48

-0.73 (-1.30%)

08:02
11/13/17
11/13
08:02
11/13/17
08:02
Hot Stocks
Merck receives positive CHMP opinion for PREVYMIS in the EU »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 14

    Dec

  • 02

    Feb

BIIB

Biogen

$310.44

0.48 (0.15%)

, PFE

Pfizer

$35.18

-0.02 (-0.06%)

07:29
11/13/17
11/13
07:29
11/13/17
07:29
Recommendations
Biogen, Pfizer, Bristol-Myers, Merck, AstraZeneca, Eli Lilly analyst commentary at BMO Capital »

BMO says Pfizer buying…

BIIB

Biogen

$310.44

0.48 (0.15%)

PFE

Pfizer

$35.18

-0.02 (-0.06%)

BMY

Bristol-Myers

$60.86

-1.13 (-1.82%)

MRK

Merck

$55.48

-0.73 (-1.30%)

AZN

AstraZeneca

$32.91

-0.2 (-0.60%)

LLY

Eli Lilly

$83.29

-0.7 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

  • 28

    Nov

  • 30

    Nov

  • 14

    Dec

  • 02

    Feb

  • 05

    Mar

SNDX

Syndax

$10.11

0.09 (0.90%)

, MRK

Merck

$55.48

-0.73 (-1.30%)

15:54
11/12/17
11/12
15:54
11/12/17
15:54
Hot Stocks
Syndax announces presentation of immuno-oncology clinical trials data »

Syndax (SNDX)…

SNDX

Syndax

$10.11

0.09 (0.90%)

MRK

Merck

$55.48

-0.73 (-1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 14

    Dec

  • 02

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.